"TNF-induced proteins in lipid signaling, inflammation, and cancer"
Class of '62, John Morgan Building
Shiroh Tanoue, MD, PhD & Yonghai Li (Kaplan Lab)
Children's Environmental Health and Disease Prevention Award
Genome Wide Analysis of TOP2 DNA Damage in Infant Leukemia Carolyn A. Felix, MD,Professor of Pediatrics, Joshua Kahan Chair in Pediatric Leukemia
Effects of Low Nicotine Cigarettes on CYP1A2 Induction Rebecca Ashare, PhD, Research Assistant Professor, Center for Interdisciplinary Research on Nicotine Addiction
Mentored Scientist Transition Award Detoxifying Antioxidant Delivery: The Characterization and Toxicity Studies of Non-polymeric Antioxidant Nanocarriers for Antioxidant Enzyme Delivery. Elizabeth Hood, PhD, Research Associate, Institute for Translational Medicine and Therapeutics (ITMAT)
Children's Environmental Health and Disease Prevention Award -
Genome Wide Analysis of TOP2 DNA Damage in Infant Leukemia Carolyn A. Felix, MD Professor of Pediatrics Joshua Kahan Chair in Pediatric Leukemia
Tobacco-Environmental Carcinogenesis Award -
Effects of Low Nicotine Cigarettes on CYP1A2 Induction Rebecca Ashare, PhD Research Assistant Professor Center for Interdisciplinary Research on Nicotine Addiction
Mentored Scientist Transition Award -
Detoxifying Antioxidant Delivery: The Characterization and Toxicity Studies of Non-polymeric Antioxidant Nanocarriers for Antioxidant Enzyme Delivery. Elizabeth Hood, PhD Research Associate Institute for Translational Medicine and Therapeutics (ITMAT)
"Structure and mechanism of metal-dependent enzymes"
African Viewpoints on Global Health and Social Change Friday Jan 31st, 3:00-5:00 Fagin Hall (Nursing Building) Room 216, 418 Curie Blvd, Philadelphia, PA 19104 Visiting scholars, Ellis Owusu-Dabo, MD, PhD of the Kumasi Center for Collaborative Research in Tropical Medicine and Yaw Asare Afrane, PhD of the Kenya Medical Research Institute will discuss their current research in Ghana and Kenya. Penn students, staff and faculty who have conducted fieldwork in Africa will also join the discussion. Light refreshments provided Sponsors SEAS, Africa Center, SOM Global Health Programs, Center for Public Health Initiatives, Global Health Affairs School of Nursing, Botswana UPenn Partnership Contact: email@example.com
Additional info about speakers: Ellis Owusu-Dabo, MD, PhD Scientific Director, Kumasi Center for Collaborative Research in Tropical Medicine (KCCR), Ghana Dr Owusu-Dabo is a Public Health Physician Specialist in Medical Epidemiology. His area of interest is mainly non-communicable disease in low-income country settings , although with interest in communicable disease, as well. Dr. Owusu-Dabo completed his B.Sc., Human Biology and MBChB in Medicine and Surgery, and M.Sc. in Public Health at Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana. Hethen completed his doctoral work at University of Nottingham, at the Division of Epidemiology and Public Health, UK. Dr Owusu-Dabo is Fellow of the West African College of Physicians in Community Health and also a Fellow of the Ghana College of Physicians and Surgeons. In his current position as Senior Lecturer and Scientific Director, Dr. Owusu-Dabo is continuing his studies of genetic susceptibility factors predisposing to pulmonary TB infection as well as elucidating the role of mRNAs in TB disease. His additional research focuses on population genomics of type II diabetes and hypertension. Dr Owusu-Dabo supports a large-scale research in Neglected Tropical Disease at the Kumasi Centre. Dr Owusu-Dabo’s ambition is to become an international biomedical scientist and public health consultant, of great repute working in collaboration with multi-nationals and universities across Africa and the rest of the world.
Yaw Asare Afrane, PhD Kenya Medical Research Institute (KEMRI) Dr. Afrane's research interests are in infectious diseases, particularly the epidemiology and control of vector borne diseases. Currently, he is working on insecticide resistance in malaria vectors, specifically to determine the impact of resistant vectors on malaria transmission. Because resistance to vectors might come with a fitness cost favouring the vector, Dr. Afrane's research aim is to determine how the fitness cost could impact the life history traits of mosquitoes, and their malaria transmission potential. On another project, he is monitoring the treatment of uncomplicated malaria with Artemisinin Combination Therapy (ACT) drugs to determine treatment failures and delayed parasite clearance. This is a longitudinal study that follows patients who get treated with ACTs in health facilities in Kenya. Patients are followed for up to 42 days to determine parasite clearance rates.